UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 74

Sortiert nach

Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?

Frontiers in immunology, 2019-09, Vol.10, p.2066-2066

2019

Link zum Volltext

Verfügbarkeit prüfen

What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?

International Journal of Molecular Sciences, 2012-10, Vol.13 (10), p.12665-12709

2012

Link zum Volltext

Verfügbarkeit prüfen

Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study

CNS drugs, 2021-08, Vol.35 (8), p.907-918

2021

Link zum Volltext

Verfügbarkeit prüfen

Induction intravenous cyclophosphamide followed by maintenance oral immunosuppression in refractory myasthenia gravis

Muscle & nerve, 2015-08, Vol.52 (2), p.204-210

2015

Link zum Volltext

Verfügbarkeit prüfen

Immune-mediated conditions affecting the brain, eye and ear (BEE syndromes)

Journal of neurology, neurosurgery and psychiatry, 2019-08, Vol.90 (8), p.882

2019

Link zum Volltext

Verfügbarkeit prüfen

Distinguishing Susac’s syndrome from multiple sclerosis

Journal of neurology, 2015-07, Vol.262 (7), p.1613-1621

2015

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium

Frontiers in immunology, 2021-01, Vol.11, p.597858-597858

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864231221331-17562864231221331

2024

Link zum Volltext

Verfügbarkeit prüfen

Cerebellar Ataxia Followed by Stiff Person Syndrome in a Patient with Anti-GAD Antibodies

Case reports in immunology, 2020, Vol.2020, p.8454532-4

2020

Link zum Volltext

Verfügbarkeit prüfen

Hsp72 Inhibits Apoptosis Upstream of the Mitochondria and Not through Interactions with Apaf-1

The Journal of biological chemistry, 2004-12, Vol.279 (49), p.51490-51499

2004

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)

JMIR research protocols, 2021-10, Vol.10 (10), p.e24969-e24969

2021

Link zum Volltext

Verfügbarkeit prüfen

072 Impact of telehealth on multiple sclerosis (MS) outpatient clinics during the COVID-19 pandemic

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A26-A27

2021

Link zum Volltext

Verfügbarkeit prüfen

010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A4-A5

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognosis in autoimmune encephalitis: Database

Data in brief, 2018-12, Vol.21, p.2694-2703

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognosticating autoimmune encephalitis: A systematic review

Journal of autoimmunity, 2019-01, Vol.96, p.24-34

2019

Link zum Volltext

Verfügbarkeit prüfen

008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A4-A4

2021

Link zum Volltext

Verfügbarkeit prüfen

Acute haemorrhagic necrotizing encephalopathy in the setting of SARS-CoV-2 vaccination: a case report and literature review

Acta neurologica Belgica, 2023-02, Vol.123 (1), p.303-305

2023

Link zum Volltext

Verfügbarkeit prüfen

Acute intermittent porphyria presenting with first episode seizure and rhabdomyolysis

Acta neurologica Belgica, 2023-08, Vol.123 (4), p.1611-1614

2023

Link zum Volltext

Verfügbarkeit prüfen

Hsp72 Inhibits Fas-mediated Apoptosis Upstream of the Mitochondria in Type II Cells

The Journal of biological chemistry, 2005-03, Vol.280 (10), p.9005-9012

2005

Link zum Volltext

Verfügbarkeit prüfen

Intrathoracic Malignancy Mimicking Axial Dystonia

Movement disorders clinical practice (Hoboken, N.J.), 2016-03, Vol.3 (2), p.203-205

2016

Link zum Volltext

Verfügbarkeit prüfen

Heat Shock Protein 72 Modulates Pathways of Stress-induced Apoptosis

The Journal of biological chemistry, 1998-07, Vol.273 (27), p.17147-17153

1998

Link zum Volltext

Verfügbarkeit prüfen

Sixteen syndrome: a rare presentation of central demyelination

BMJ case reports, 2023-01, Vol.16 (1)

2023

Link zum Volltext

Verfügbarkeit prüfen

Seizures in autoimmune encephalitis: Kindling the fire

Epilepsia (Copenhagen), 2020-06, Vol.61 (6), p.1033-1044

2020

Link zum Volltext

Verfügbarkeit prüfen

009 Predicting infection risk in multiple sclerosis patients treated with ocrelizumab: a retrospective cohort study

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A4-A4

2021

Link zum Volltext

Verfügbarkeit prüfen

Defining secondary progressive multiple sclerosis

Brain (London, England : 1878), 2016-09, Vol.139 (Pt 9), p.2395-2405

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(71)
Berichte
(3)

Sprache

Englisch
(74)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?

What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?

Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study

Induction intravenous cyclophosphamide followed by maintenance oral immunosuppression in refractory myasthenia gravis

Immune-mediated conditions affecting the brain, eye and ear (BEE syndromes)

Distinguishing Susac’s syndrome from multiple sclerosis

Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium

Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies

Cerebellar Ataxia Followed by Stiff Person Syndrome in a Patient with Anti-GAD Antibodies

Hsp72 Inhibits Apoptosis Upstream of the Mitochondria and Not through Interactions with Apaf-1

Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)

072 Impact of telehealth on multiple sclerosis (MS) outpatient clinics during the COVID-19 pandemic

010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort

Prognosis in autoimmune encephalitis: Database

Prognosticating autoimmune encephalitis: A systematic review

008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis

Acute haemorrhagic necrotizing encephalopathy in the setting of SARS-CoV-2 vaccination: a case report and literature review

Acute intermittent porphyria presenting with first episode seizure and rhabdomyolysis

Hsp72 Inhibits Fas-mediated Apoptosis Upstream of the Mitochondria in Type II Cells

Intrathoracic Malignancy Mimicking Axial Dystonia

Heat Shock Protein 72 Modulates Pathways of Stress-induced Apoptosis

Sixteen syndrome: a rare presentation of central demyelination

Seizures in autoimmune encephalitis: Kindling the fire

009 Predicting infection risk in multiple sclerosis patients treated with ocrelizumab: a retrospective cohort study

Defining secondary progressive multiple sclerosis

Suchergebnisse filtern